Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis

The multi-biomarker disease activity (MBDA) score measures 12 proteins involved in the pathophysiology of rheumatoid arthritis (RA) to assess disease activity (DA). Previous studies demonstrated correlations between MBDA and clinical DA scores with some RA therapies. In this analysis, the relationsh...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiss, William G., Devenport, Jenny N., Low, Jason M., Wu, George, Sasso, Eric H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Short Communication - Validation Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723630/
https://www.ncbi.nlm.nih.gov/pubmed/26026604
http://dx.doi.org/10.1007/s00296-015-3285-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723630/
https://www.ncbi.nlm.nih.gov/pubmed/26026604
http://dx.doi.org/10.1007/s00296-015-3285-2

Ejemplares similares